Morningstar
•
Jun 14, 2022
GoodRx Holdings, Inc.: Placing GoodRx Under Review
Summary
GoodRx is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It has over 6 million active monthly users. The company’s primary focus is the U.S. prescription drug market, where GoodRx has developed a price comparison tool that it aggregates from over 200 billion daily pricing data points, directing consumers toward coupons negotiated between a pharmacy and intermediaries (pharmacy benefit managers ). GoodRx generates revenue by taking a small share of the fees paid by pharmacies to PBMs in exchange fo
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
DOCS: Raising target price to $20.00
Jul 01, 2026
•
DOCS
GTM: What does Argus have to say about GTM?
Jul 01, 2026
•
GTM
DOCS: Lowering target price to $19.00
Jun 24, 2026
•
DOCS
GTM: What does Argus have to say about GTM?
Jun 24, 2026
•
GTM
DOCS: Raising target price to $20.00
Jun 17, 2026
•
DOCS
